Laboratory findings of postoperative venous thromboembolism (VTE) in Dr. Sardjito General Hospital, Yogyakarta

  • Supomo Division of Cardiothoracic and Vascular Surgery, Department of Surgery, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada/Dr. Sardjito General Hospital, Yogyakarta
  • Budi Mulyono Department of Clinical Pathology and Laboratory Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada/Dr. Sardjito General Hospital, Yogyakarta,
  • Usi Sukorini Department of Clinical Pathology and Laboratory Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada/Dr. Sardjito General Hospital, Yogyakarta
  • Adika Zhulhi Arjana Department of Clinical Pathology and Laboratory Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada/Dr. Sardjito General Hospital, Yogyakarta
  • Tandean Tommy Novenanto 3Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia
Keywords: postoperative;, venous thromboembolism;, neutrophil to lymphocyte ratio;, complete blood count;, pulmonary embolism

Abstract

Venous thromboembolism (VTE) is a significant risk, especially for older individuals. Indonesian studies found 37.1% VTE incidence in bedridden patients over 40 and 2.1% in major surgeries. Surgery, like hip fractures, raises the risk temporarily. Diagnosis relies on tests like ultrasound with Doppler, Wells score, and neutrophil-to-lymphocyte ratio (NLR). This study aimed to evaluate the laboratory findings of postoperative VTE. A retrospective analysis was conducted in Dr. Sardjito General Hospital, Yogyakarta using medical record data of VTE patients who underwent major surgery. The laboratory data, including complete blood count characteristics for every month for three months after postsurgery and DVT presentation when it occurred on the diagnostic day were collected. In total of 27 patients involved in this study, VTE cases were more common in digestive (41.2%) and obstetric gynecology surgeries (29.4%) for females, and nervous (44.4%) and cardiovascular surgeries (22.2%) for males. Females had a higher prevalence of Well Score ≥3 (82.4% vs 40%; p=0.058) and longer VTE therapy durations (65.50 ± 46.51 vs 39.60 ± 41.04 d; p=0.172). Males had more unilateral VTE occurrences (90.9 vs 56.3%; p=0.070) and a higher proportion of total occlusion cases (60 vs 37.5%; p=0.422). NLR exhibited a significant decrease from the 1st to the 2nd month (10.52 vs 3.64; p=0.009), followed by an insignificant increase in the 3rd month (3.64 vs 3.98; p=0.878). Notably, NLR trended downward in the 2nd month examination. In conclusion, VTE occurs in 0.21% of postoperative patients, with the highest incidence observed in post-gynecological surgery patients. The NLR can serve as a diagnostic tool for VTE in extremities, as an elevated NLR indicates the presence of a more proximal thrombus.

References

Phillippe HM. Overview of venous thromboembolism. Am J Manag Care 2017; 23(20 Suppl):S376-82.

Heit JA. Epidemiology of venous thromboembolism. Nat Rev Cardiol 2015; 12(8):464-74.

https://doi.org/10.1038/nrcardio.2015.83

Faioni EM, Zighetti ML, Vozzo NP. Sex, gender and venous thromboembolism: do we care enough? Blood Coagul Fibrinolysis 2018; 29(8):663-7.

https://doi.org/10.1097/MBC.0000000000000773

Tambunan KL, Kurnianda J, Suharti C, Wardhani SO, Sukrisman L, Soetandyo N, et al. IDENTIA Registry: incidence of deep vein thrombosis in medically ill subjects at high risk in Indonesia: a prospective study. Acta Med Indones 2020; 52(1):14-24.

Susanto AP, Krisnanda C, Tan DSY, Ong HY, Pratama D, Soeparwata R. Incidence of venous thromboembolism among patients who underwent major surgery in a public hospital in Singapore. Med J Indones 2014; 23(1):36-41.

https://doi.org/10.13181/mji.v23i1.687

Khan F, Tritschler T, Kahn SR, Rodger MA. Venous thromboembolism. Lancet 2021; 398(10294):64-77.

https://doi.org/10.1016/S0140-6736(20)32658-1

Schulman S, Ageno W, Konstantinides SV. Venous thromboembolism: Past, present and future. Thromb Haemost 2017; 117(7): 1219-29.

https://doi.org/10.1160/TH16-10-0823

Rinaldi I, Hamonangan R, Azizi MS, Cahayanur R, Wirawan F, Fatya AI, et al. Diagnostic value of neutrophil lymphocyte ratio and d-dimer as biological markers of deep vein thrombosis in patients presenting with unilateral limb edema. J Blood Med 2021; 12:313-25.

https://doi.org/10.2147/JBM.S291226

Lin HY, Lin CY, Huang YC, Hsieh HN, Yang YW, ChangIL, et al. Deep vein thrombosis after major orthopedic surgery in Taiwan: a prospective cross-sectional study and literature review. J Formos Med Assoc 2022; 121(8):1541-49.

https://doi.org/10.1016/j.jfma.2021.12.027

Expósito-Ruiz M, Arcelus JI, Caprini JA, Lopez-Espada C, Bura-Riviere A, Amado C, et al. Timing and characteristics of venous thromboembolism after noncancer surgery. J Vasc Surg Venous Lymphat Disord 2021; 9(4):859-67.e2.

https://doi.org/10.1016/j.jvsv.2020.11.017

Crous-Bou M, Harrington LB, Kabrhel C. Environmental and genetic risk factors associated with venous thromboembolism. Semin Thromb Hemost 2016; 42(8):808-20.

https://doi.org/10.1055/s-0036-1592333

Heit JA. Epidemiology of venous thromboembolism. Nat Rev Cardiol 2015; 12(8):464-74.

https://doi.org/10.1038/nrcardio.2015.83

Kim JYS, Khavanin N, Rambachan A, McCarthy RJ, Mlodinow AS, De Oliveria GS Jr, et al. Surgical duration and risk of venous thromboembolism. JAMA Surg 2015; 150(2):110-7.

https://doi.org/10.1001/jamasurg.2014.1841

Cantrell LA, Garcia C, Maitland HS. Thrombosis and thromboprophylaxis in gynecology surgery. Clin Obstet Gynecol 2018; 61(2):269-77.

https://doi.org/10.1097/GRF.0000000000000355

Insin P, Vitoopinyoparb K, Thadanipon K, Charakorn C, Attia J, McKay GJ, et al. Prevention of venous thromboembolism in gynecological cancer patients undergoing major abdominopelvic surgery: a systematic review and network meta-analysis. Gynecol Oncol 2021; 161(1):304-13.

https://doi.org/10.1016/j.ygyno.2021.01.027

Ismail I, Tobing DA, Bachtiar A, Siregar UP, Tambunan KL. Protein C, protein S, antithrombin III, and hyperfibrinogenemia in deep vein thrombosis (DVT) among patients who underwent high risk orthopaedic surgery. Med J Indones 2004; 13(1):24-30.

https://doi.org/10.13181/mji.v13i1.130

Ali N, Ayyub M, Khan SA. High prevalence of protein C, protein S, antithrombin deficiency, and factor V Leiden mutation as a cause of hereditary thrombophilia in patients of venous thromboembolism and cerebrovascular accident. Pak J Med Sci 2014; 30(6):1323-6.

https://doi.org/10.12669/pjms.306.5878

Afari ME, Bhat T. Neutrophil to lymphocyte ratio (NLR) and cardiovascular diseases: an update. Expert Rev Cardiovasc Ther 2016; 14(5):573-7.

https://doi.org/10.1586/14779072.2016.1154788

Kurtipek E, Büyükterzi Z, Büyükterzi M, Alpaydın MS, Erdem SS. Endothelial dysfunction in patients with pulmonary thromboembolism: neutrophil to lymphocyte ratio and platelet to lymphocyte ratio. Clin Respir J 2017; 11(1):78-82.

https://doi.org/10.1111/crj.12308

Colling ME, Tourdot BE, Kanthi Y. Inflammation, infection and venous thromboembolism. Cir Res 2021; 128(12):2017-36.

https://doi.org/10.1161/CIRCRESAHA.121.318225

Otasevic V, Mihaljevic B, Milic N, Stanisavljevic D, Vukovic V, Tomic K, et al. Immune activation and inflammatory biomarkers as predictors of venous thromboembolism in lymphoma patients. Thromb J 2022; 20(1):20.

https://doi.org/10.1186/s12959-022-00381-3

Liebman HA. Cancer prognosis in patients with venous thromboembolism (VTE) and patients with clinical and laboratory biomarkers predictive of VTE risk. Thromb Res 2018; 164 Suppl 1:S19-22.

https://doi.org/10.1016/j.thromres.2018.01.040

Hu J, Cai Z, Zhou Y. The association of neutrophil–lymphocyte ratio with venous thromboembolism: a systematic review and meta-analysis. Clin Appl Thromb Hemost 2022; 28:10760296221130061.

https://doi.org/10.1177/10760296221130061

Niu S, Pei Y, Hu X, Ding D, Jiang G. Relationship between the neutrophil-to-lymphocyte ratio or platelet-to-lymphocyte ratio and deep venous thrombosis (DVT) following femoral neck fractures in the elderly. Front Surg 2022; 9:1001432.

https://doi.org/10.3389/fsurg.2022.1001432

Kearon C, de Wit K, Parpia S, Schulman S, Spencer FA, Sharma S, et al. Diagnosis of deep vein thrombosis with D-dimer adjusted to clinical probability: prospective diagnostic management study. BMJ 2022; 376:e037378.

https://doi.org/10.1136/bmj-2021-067378

Rinaldi I, Hamonangan R, Azizi MS, Cahyanur R, Wirawan F, Fatya AI, et al. Diagnostic value of neutrophil lymphocyte ratio and D-dimer as biological markers of deep vein thrombosis in patients presenting with unilateral limb edema. J Blood Med 2021; 12:313-25.

https://doi.org/10.2147/JBM.S291226

Sujana KY, Semadi IN, Mahadewa TGB. The correlation of neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio compared to D-dimer as a diagnostic test in deep vein thrombosis (DVT). Bali Medical Journal 2020; 9(2):546-52.

https://doi.org/10.15562/bmj.v9i2.1793

Yamagata K, Fukuzawa S, Uchida F, Ishibashi-Kanno N, Yanagawa T, Bukawa H. Is preoperative plate-lymphocyte ratio a predictor of deep vein thrombosis in patients with oral cancer during surgery? J Oral Maxillofac Surg 2021; 79(4):914-24.

https://doi.org/10.1016/j.joms.2020.10.024

Grilz E, Posch F, Königsbrügge O, Schwarzinger I, Lang IM, Marosi C, et al. Association of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio with the risk of thromboembolism and mortality in patients with cancer. Thromb Haemost 2018; 118(11):1875-84.

https://doi.org/10.1055/s-0038-1673401

Siddiqui F, García-Ortega A, Kantarcioglu B, Sinacore J, Tafur A, Demelo-Rodríguez P, et al. Cellular indices and outcome in patients with acute venous thromboembolism. Clinical Appl Thromb Hemost 2022; 28:10760296221113346.

https://doi.org/10.1177/10760296221113346

Gao Z, Zhao K, Jin L, Lian X, Zhang Z, Ma L, et al. Combination of neutrophil to lymphocyte ratio, platelet to lymphocyte ratio with plasma D-dimer level to improve the diagnosis of deep venous thrombosis (DVT) following ankle fracture. J Orthop Surg Res 2023; 18(1):362.

https://doi.org/10.1186/s13018-023-03840-3

Farah R, Nseir W, Kagansky D, Khamisy‐Farah R. The role of neutrophil‐lymphocyte ratio, and mean platelet volume in detecting patients with acute venous thromboembolism. J Clin Lab Anal 2020; 34(1):e23010.

https://doi.org/10.1002/jcla.23010

McLeod B, Lim HY, Nandurkar H, Ho P, Wang J. Overall hemostatic potential assay detects risk of progression to post-thrombotic syndrome in anticoagulated patients following deep vein thrombosis. Diagnostics 2022; 12(12):3165.

https://doi.org/10.3390/diagnostics12123165

Grimnes G, Horvei LD, Tichelaar V, Brækkan SK, Hansen JB. Neutrophil to lymphocyte ratio and future risk of venous thromboembolism and mortality: the Tromsø Study. Haematologica 2016; 101(10):e401-4.

https://doi.org/10.3324/haematol.2016.14515

Etli M, Karahan O, Serhatlıoglu F, Ontas H. Evaluation of the predictive role of standard laboratory tests for disease severity in patients with deep venous thrombosis. Acta Angiologica 2022; 28(1):16-21.

https://doi.org/10.5603/AA.2022.0001

Kuplay H, Erdoğan SB, Bastopcu M, Arslanhan G, Baykan DB, Orhan G. The neutrophil-lymphocyte ratio and the platelet-lymphocyte ratio correlate with thrombus burden in deep venous thrombosis. J Vasc Surg Venous Lymphat Disord 2020; 8(3):360-4.

https://doi.org/10.1016/j.jvsv.2019.05.007

Published
2024-06-26
Section
Articles